When Ronald Ross examined an Anopheles mosquito in Secunderabad, India, on August 20, 1897, he found the malaria parasite in the insect after it had fed on an infected person. The observation confirmed the link between the mosquito and the transmission of the disease. Ross called the date "Mosquito Day" and received the Nobel Prize in Medicine in 1902.

The anniversary commemorates this discovery, but the mosquito that is a public health concern does not belong to a single species or a single continent. Anopheles mosquitoes transmit malaria. Aedes mosquitoes can transmit dengue fever, yellow fever, chikungunya, and Zika. Culex mosquitoes are associated with diseases such as West Nile fever and Japanese encephalitis.

This diversity explains why a day dedicated to the mosquito has global significance. In 2024, dengue fever reached record levels, and the WHO recorded 11.201 deaths across its six regions of the world. More than 90% of cases were registered in the Americas, with Brazil accounting for more than ten million reported infections.

The geography of risk is also changing. Urbanization without adequate infrastructure, domestic water storage, changes in temperature and rainfall, international travel, and trade create new opportunities for vectors. Dengue fever has already appeared in more than one hundred countries.

Other mosquito-borne diseases move between tropical and temperate zones with an ease that defies traditional sanitary boundaries. The size of the insect is, therefore, a distraction.

The real problem lies in the intersection between biology and human conditions: water, housing, sanitation, surveillance, income, health services, and the public capacity to act early. The same mosquito can be a nuisance in a protected neighborhood and become a vector for an epidemic where the state arrives too late.

In malaria, inequality manifests itself with a statistical violence that is difficult to overcome. In 2024, the WHO estimated 610 deaths in 80 countries. Almost half of the world's population lived in at-risk areas. Even so, the African Region accounted for 265 million cases and 579 deaths, approximately 95% of all global mortality.

The numbers become stark when you look at the age group. Three-quarters of malaria deaths in the African Region have occurred among children under five. The disease can be prevented and treated, but a fever that could be diagnosed and treated can become fatal when the clinic is far away, tests are lacking, or the health center lacks medication.

This African concentration does not make malaria an exclusively African disease. The Eastern Mediterranean Region is estimated to have 11,1 million cases and 22.100 deaths in 2024, with a large share in Sudan, Pakistan, and Yemen. Asia continues to face transmission in several countries, while the Americas maintain persistent outbreaks that require ongoing diagnosis, treatment, and surveillance.

There are also countries that show the opposite trend. The WHO had certified 47 countries and one territory as malaria-free by 2025. In the Greater Mekong region, indigenous cases of Plasmodium falciparum fell by almost 90% between 2015 and 2024. Egypt was certified in 2024. Georgia, Suriname, and Timor-Leste officially received WHO certification in 2025.

The difference between these pathways reveals, on World Mosquito Day, the political nature of transmission. Rain and temperature influence the mosquito, but they alone do not decide who receives a treated net, who finds a rapid test, who receives early treatment, and who depends on a clinic without medication.

Inequality transforms a known infection into an unequal outcome between and within countries.

The main contradiction regarding malaria, also evident on World Mosquito Day, is this: the prevention arsenal has grown while coverage remains incomplete. Insecticide-treated mosquito nets and residual spraying inside homes remain fundamental.

Rapid diagnosis and combination treatments based on artemisinin reduce the risk of severe disease when they are implemented early and used correctly. The nets have also changed. Mosquito resistance to pyrethroids has reduced the effectiveness of older models in many areas.

The WHO has started recommending nets with two active ingredients for areas where this resistance is present. The change shows that an effective tool doesn't last by decree: it needs research, adequate procurement, regular distribution, and data on the vector.

Vaccination has added a level of protection that for decades seemed distant. The WHO now recommends two vaccines against Plasmodium falciparum malaria for children in endemic areas: RTS,S and R21. By March 2026, 25 African countries had introduced them into routine vaccination programs, with international support and more than 39 million doses delivered.

The initial results leave little room for dismissing this change. An assessment released by the WHO in May 2026 estimated that, over four years, the introduction of RTS,S in Ghana, Kenya, and Malawi prevented one in eight child deaths among children eligible for vaccination. The benefit emerged when the vaccine was added to existing measures.

The vaccine, however, does not replace the network, diagnosis, chemoprevention, or treatment. The WHO recommends that it be integrated into national programs. This combination is crucial because no barrier is perfect. Immunization reduces the risk. The network reduces bites. Medication prevents a treatable infection from progressing to severe forms. The strength lies in combined coverage.

The tools advance, but the mosquito, the parasite, and the social systems also change. On World Mosquito Day, drug resistance became central. The 2025 global report identified confirmed or suspected partial resistance to artemisinin in at least eight African countries.

If treatments lose effectiveness, the delay between infection and cure will cost lives where there are few therapeutic alternatives. Insecticides face similar pressure. By 2026, the WHO indicated resistance to pyrethroids in 48 of the 53 countries with data.

There are still shortcomings in the diagnosis: genetic alterations of the parasite capable of escaping some rapid tests have already been reported by dozens of endemic countries. Each of these changes requires laboratory monitoring before it can lead to clinical failure.

Another risk arrived in Africa via an unexpected biological route. Anopheles stephensi, originally from parts of South Asia and the Arabian Peninsula, has expanded across the continent and has already been detected in nine African countries. Unlike traditional malaria vectors, it adapts to cities and reproduces in artificial water containers, bringing transmission closer to dense urban areas.

Climate adds risk but is not the sole explanation. Temperature and precipitation can alter mosquito survival, the duration of transmission periods, and the presence of vectors in other territories. At the same time, cities without drainage, stored water, and poorly protected housing transform these environmental conditions into unequal human risk across neighborhoods.

Conflicts complete the picture because they disrupt precisely what malaria requires: continuity. A closed health center, an unsafe road, a delayed campaign, or a displaced family can break the chain between prevention, testing, and treatment. Sudan demonstrates this fragility in a context of war.

The promising answer doesn't fit into the story of a single institution. R21 was developed by the University of Oxford with the Serum Institute of India and other partners. The phase three trial involved more than 4.800 children in Burkina Faso, Mali, Kenya, and Tanzania. The research took place in African centers with experience in real-world transmission.

This matters because malaria science depends on where the disease circulates, an issue also present on World Mosquito Day. Institutions from these four African countries participated in the R21 clinical trials with international partners.

The knowledge produced in Africa has helped to measure the effectiveness, safety, seasonality, and vaccination strategies in populations exposed to transmission intensities.

But having scientific capacity doesn't just mean participating in trials. It means maintaining laboratories capable of identifying resistance, entomological surveillance networks, genetic sequencing, researchers with stable careers, funded universities, and regulatory authorities capable of making autonomous decisions.

It also means manufacturing more tests, medicines, insecticides, and vaccines closer to the populations that depend on them, reducing delays and vulnerabilities in supply chains.

This ambition is hampered by a material problem. In 2024, funding for malaria stood at $3,9 billion, only 42% of the $9,3 billion considered necessary for the WHO's 2025 target. Endemic countries have increased their share of funding, but remain exposed to external cuts.

World Mosquito Day becomes political. Science has shown that transmission can be reduced and that countries can eliminate malaria. Basic knowledge about the enemy has existed for a long time. What is lacking is transforming knowledge into universal protection, funding systems that don't stop between campaigns, and ensuring that innovation reaches the communities where the risk is greatest.

Malaria remains present in 80 countries, dengue fever spans all WHO regions, and environmental changes are reshaping the geography of vectors capable of rapidly adapting to cities and human borders. Will this World Mosquito Day help in the fight against these diseases?

Africa suffers the deepest wound because it accounts for almost all of the world's malaria mortality, especially among young children. This reality does not result from a lack of resources. It results from the distance between the resources and the family: insufficient funding, interrupted services, biological resistance, precarious housing, conflicts, and health systems that do not always arrive before the disease strikes.

If the world wants to transform this anniversary into a measure of progress, it will have to judge each new vaccine, each network, and each discovery by the real access it produces. The mosquito will remain small. Inequality doesn't need to remain gigantic.